accountAbbott Laboratories will pay $400 million to acquire an eye-care device company specializing in technology used to treat patients with cataracts. North Chicago-based Abbott this afternoon said it plans to pay...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Abbott to buy eye care technology firm for $400 million
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account